Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Clinical trial NCT05503108 · SUSPENDED

Trial details

NCT number: NCT05503108
Sponsor: Leiden University Medical Center
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Fasting Mimicking Diet HER2-negative Breast Cancer Hormone Receptor-positive Breast Cancer Pathological Complete Response Objective Response Rate Neoadjuvant Chemotherapy

Start date: 2023-03-17
Primary completion: 2024-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.